Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Jun 2021 for Aditx Therapeutics, Inc., €1,175. Read the official filing
Filing timeline
BuySaleShahrokh Shabahang
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Shahrokh Shabahang: trading record in brief
Shahrokh Shabahang (senior executive) discloses dealings in Aditxt, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 25 May 2021 to 1 June 2021.
Purchases make up the whole of the open-market record (2 purchases, €1,722). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 2 June 2021, the filings show an open-market purchase worth €1,175 in Aditxt, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shahrokh Shabahang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
490 shares@ US$2.9368.3% of flowCommon StockSEC:0001213900-21-030557:0
Canonical exit: 30 Aug 2021 (T+90)
279 shares@ US$2.4031.7% of flowCommon StockSEC:0001213900-21-030054:0
Canonical exit: 23 Aug 2021 (T+90)
2 of 2 declarations
